20 March 2020 - Teva will donate 6 million tablets through wholesalers to hospitals by March 31, and more than 10 million within a month.

Teva Pharmaceuticals announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulphate tablets through wholesalers to hospitals across the U.S. to meet the urgent demand for the medicine as an investigational target to treat COVID-19. The company is also looking at additional ways to address the global need.

Additional production of hydroxychloroquine sulphate tablets is also being assessed and subsequently ramped up with materials that are being sent to Teva from our ingredient supplier. Teva will ship 6 million tablets through wholesalers to hospitals by March 31, and more than 10 million within a month.

Read Teva Pharmaceuticals press release